Nuvectis Pharma (NVCT) Return on Assets (ROA)

Price: $8.495
Market Cap: $198.71M
Avg Volume: 114.56K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -0.12
52W Range: $4.44-11.8
Website: Nuvectis Pharma

Nuvectis Pharma Return on Assets (ROA) Summary

Nuvectis Pharma's ROA indicates the return generated on the company's assets:

  • Annual: -102.11%
  • Quarterly: -33.58%
  • TTM: -102.11%

What is Return on Assets (ROA)?

Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.

Related Metrics

Other important metrics to assess Nuvectis Pharma's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: -195.61%
    • Quarterly: -64.33%
    • TTM: -160.83%
  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: 0.00%
    • Quarterly: -66.40%
    • TTM: -203.87%
  • Return on Tangible Assets - measures the return generated on the company's tangible assets:
    • Annual: -102.11%
    • Quarterly: -33.58%
    • TTM: -102.11%
  • Profit Margin - shows the percentage of revenue that has turned into profit:
    • Annual: 0.00%
    • Quarterly: 0.00%
    • TTM: 0.00%

These metrics provide insights into Nuvectis Pharma's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROA

-102.11%

Quarterly ROA

-33.58%

TTM ROA

-102.11%

Nuvectis Pharma Historical ROA
4.24%4.24%-61.70%-61.70%-127.63%-127.63%-193.57%-193.57%ROA20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical ROE
200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%ROE20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical ROIC
100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%-300.00%-300.00%-400.00%-400.00%ROIC20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Profit Margin
0.00%0.00%-3000.00%-3000.00%-6000.00%-6000.00%-9000.00%-9000.00%-12000.00%-12000.00%-15000.00%-15000.00%Profit Margin20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Return on Tangible Assets
4.24%4.24%-61.70%-61.70%-127.63%-127.63%-193.57%-193.57%Return on Tangible Assets20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Nuvectis Pharma Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROA ROE ROIC Profit Margin Return on Tangible Assets
2024 -102.11% -195.61% 0.00% 0.00% -102.11%
2023 -116.03% -182.44% -187.66% 0.00% -116.03%
2022 -92.07% -132.13% -133.16% -12608.72% -92.07%
2021 -193.57% 117.06% -304.15% 0.00% -193.57%
2020 0.00% 100.00% 99.76% 0.00% 0.00%

Related Metrics

Explore detailed financial metrics and analysis for NVCT.